Welcome to our dedicated page for Columbia Financial, Inc./MD/ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Columbia Financial, Inc./MD/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Columbia Financial, Inc./MD/'s regulatory disclosures and financial reporting.
Columbia Financial, Inc. executive Allyson Katz Schlesinger, SEVP & Head of Consumer Banking, purchased a total of 50,000 shares of Common Stock of CLBK on July 20, 2026 at $10.00 per share, split between 44,400 directly held shares and 5,600 shares acquired through a 401(k) plan. Following these transactions, she directly holds 192,490 Common shares and also has various indirect Common Stock holdings through stock-based deferral, SERP, ESOP, SIM, and stock award vehicles, as well as multiple outstanding stock option positions with exercise prices between $7.10 and $8.31.
Columbia Financial, Inc. director James Michael Kuiken reported purchasing 10,000 shares of common stock on July 20, 2026 at $10.00 per share, held indirectly through an IRA. Following this purchase, he reported 10,000 indirect IRA shares, 35,356 directly held shares, and 6,494 additional indirect shares as stock awards that vest on March 12, 2027 under the 2019 Equity Incentive Plan.
Columbia Financial, Inc./MD/ executive Allyson Katz Schlesinger, SEVP & Head of Consumer Banking, reports initial equity holdings. She holds stock options on Common Stock with exercise prices from 7.1000 to 8.3100 per share covering blocks of 34,1646.0000, 27,790.0000, 20,442.0000, 46,835.0000, and 47,000.0000 underlying shares, expiring between 2029 and 2036. She also reports 148,090.0000 Common shares held directly and additional indirect holdings through a stock-based deferral plan, ESOP, SERP, SIM, and multiple stock award programs.
Columbia Financial, Inc./MD/ reported the initial beneficial ownership of director Paul Stahlin on a Form 3. The filing lists 57,000 shares of Common Stock held as an indirect interest "By IRA." No specific buy or sell transaction is reported; the entry reflects a holding position as of the reported date.
Columbia Financial, Inc./MD/ director Michael Massood Jr. filed an initial ownership report detailing his equity positions in the company. He reports 183,246 stock options with an exercise price of $7.10 per share, exercisable into common stock until July 23, 2029. He also reports direct ownership of 94,613 shares of common stock, as well as indirect holdings of 78,063 shares through a Roth IRA, 47,044 shares through an IRA, and 6,494 shares through a stock award vehicle.
Columbia Financial, Inc./MD/ reported initial holdings for director James Michael Kuiken. He is listed as directly holding 35,356 shares of Common Stock and indirectly holding 6,494 shares described as held "By Stock Award V." These entries establish his reportable ownership positions as of 2026-07-20.
Columbia Financial, Inc./MD/ director Elizabeth E. Randall reported her initial ownership of company securities. She holds stock options covering 137,442 shares of common stock with an exercise price of $7.10 per share, expiring on July 23, 2029. She also reports direct ownership of 94,910 common shares, plus indirect holdings of 21,984 shares through a stock-based deferral plan, 97,783 shares through an IRA, 14,749 shares through a Roth IRA, and 6,494 shares through a Stock Award V arrangement.
Columbia Financial, Inc./MD/ executive Lewis Oliver Edward Jr, SEVP & Head Commercial Banking, reports his equity holdings in Columbia Financial common stock and stock options as of 2026-07-20. These include multiple tranches of stock options with stated exercise prices and expiration dates, as well as direct and indirect common stock positions held through various employee and stock-based plans.
Columbia Financial, Inc./MD/ director WAINWRIGHT JIM HOBART reported his initial holdings of the company’s Common Stock. He holds 7,055 shares directly, plus 4,389 shares held indirectly "By ESOP" and 6,494 shares held indirectly "By Stock Award" as of July 20, 2026.
Columbia Financial, Inc./MD/ director Lucy Sorrentini reported her initial ownership of the company’s Common Stock. As of July 20, 2026, she held 32,716 shares directly, plus 16,896 shares held indirectly through a stock-based deferral plan and 6,494 shares held indirectly via a stock award vehicle.